Healthcare · NSE: CONCORDBIO
Concord Biotech Limited
₹1,268.50
-7.77% · close 28 Oct 2026
52-week range
₹1,014.80 – ₹1,587.50
From 52W high
-20.09%
Return 1Y
-11.42%
Volume · Avg 20D
3.80 L · 1.10 L
Returns & technicals
1W-0.12%
1M-12.73%
3M+0.99%
6M+19.91%
1Y-11.42%
| 50-day average | ₹1,432.19 below |
| 200-day average | ₹1,269.00 below |
| Volatility (1Y, annualised) | 41.71% |
| RSI (14) | 40.8 |
| MACD histogram (12, 26, 9) | -1.14 |
| Delivery · 20D avg | 34.17% · 46.24% |
| Signals | volume 4.0x |
| Turnover (last day) | ₹49 Cr |
Profile
| Symbol | CONCORDBIO |
| ISIN | INE338H01029 |
| Sector | Healthcare |
| Listed on NSE | 18 Aug 2023 |
| Face value | ₹1 |
| Series | EQ |
Financials & shareholding
Quarterly results and the shareholding pattern for CONCORDBIO aren't available right now.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |